Kanamic Network Co., LTD. (JP:3939)
:3939
Top Page
Kanamic Network Co., LTD.
(3939)
Select Model
Select Model
Rating:75Outperform
Price Target:
¥555.00
▲(6.32% Upside)
Action:ReiteratedDate:02/07/26
Overall score is driven primarily by strong financial performance (high margins, low leverage, and strong cash conversion). Technicals are supportive via an uptrend versus moving averages, but negative MACD tempers momentum. Valuation is moderate-to-expensive with a modest dividend yield, limiting upside from a valuation standpoint.
Positive Factors
High Profitability
Sustained high gross and operating margins reflect scalable, high-value software economics in healthcare. Durable profitability supports reinvestment in product development, funds operating needs, and provides a buffer against competitive pressure over a multi-month horizon.
Negative Factors
Modest Revenue Growth
Top-line growth at ~2.4% is modest for a tech-enabled services provider, suggesting limited market expansion or slower new-client wins. Over months this constrains scalability and may force management to rely on margin or cost levers to sustain earnings growth.
Read all positive and negative factors
Positive Factors
Negative Factors
High Profitability
Sustained high gross and operating margins reflect scalable, high-value software economics in healthcare. Durable profitability supports reinvestment in product development, funds operating needs, and provides a buffer against competitive pressure over a multi-month horizon.
Read all positive factors
Kanamic Network Co., LTD. (3939) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥24.00B
Dividend Yield1.39%
Average Volume (3M)112.84K
Price to Earnings (P/E)20.3
Beta (1Y)0.63
Revenue Growth9.85%
EPS Growth20.83%
CountryJP
Employees279
SectorHealthcare
Sector Strength45
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)6.44
Shares Outstanding48,132,000
10 Day Avg. Volume181,740
30 Day Avg. Volume112,836
Financial Highlights & Ratios
PEG Ratio0.97
Price to Book (P/B)4.83
Price to Sales (P/S)4.08
P/FCF Ratio19.52
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)28.4
Revenue Forecast (FY)¥6.35B
Kanamic Network Co., LTD. Business Overview & Revenue Model
Company Description
Kanamic Network Co.,LTD provides medical and elderly care information sharing system that promotes community comprehensive care in Japan. It offers medical care and elderly care communications system that provides cloud information sharing system,...
How the Company Makes Money
null...
Kanamic Network Co., LTD. Financial Statement Overview
Summary
Income Statement
85
Very Positive
Balance Sheet
78
Positive
Cash Flow
82
Very Positive
| Breakdown | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 5.50B | 5.01B | 3.75B | 2.50B | 2.08B |
| Gross Profit | 3.54B | 3.07B | 2.59B | 2.10B | 1.79B |
| EBITDA | 2.04B | 1.71B | 1.40B | 1.16B | 977.47M |
| Net Income | 1.11B | 919.99M | 763.10M | 685.52M | 579.58M |
Balance Sheet | |||||
| Total Assets | 6.54B | 6.18B | 5.65B | 6.51B | 4.40B |
| Cash, Cash Equivalents and Short-Term Investments | 3.33B | 3.43B | 2.87B | 4.55B | 3.71B |
| Total Debt | 657.68M | 932.01M | 1.28B | 3.22B | 2.00B |
| Total Liabilities | 1.89B | 2.34B | 2.48B | 3.96B | 2.44B |
| Stockholders Equity | 4.65B | 3.83B | 3.17B | 2.55B | 1.96B |
Cash Flow | |||||
| Free Cash Flow | 1.15B | 1.15B | 789.13M | 478.91M | 534.29M |
| Operating Cash Flow | 1.29B | 1.51B | 1.43B | 803.27M | 756.75M |
| Investing Cash Flow | -743.55M | -343.84M | -842.25M | -457.20M | -216.03M |
| Financing Cash Flow | -651.11M | -613.68M | -2.27B | 488.97M | 1.46B |
Kanamic Network Co., LTD. Technical Analysis
Negative
522.00
Price Trends
518.46
Negative
522.48
Negative
488.62
Positive
Market Momentum
-5.88
Positive
46.18
Neutral
68.38
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3939, the sentiment is Negative. The current price of 522 is above the 20-day moving average (MA) of 516.10, above the 50-day MA of 518.46, and above the 200-day MA of 488.62, indicating a neutral trend. The MACD of -5.88 indicates Positive momentum. The RSI at 46.18 is Neutral, neither overbought nor oversold. The STOCH value of 68.38 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:3939.
Kanamic Network Co., LTD. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥24.00B | 20.27 | ― | 1.39% | 9.85% | 20.83% | |
67 Neutral | ¥9.77B | 38.97 | ― | 5.30% | 0.09% | -48.79% | |
63 Neutral | ¥65.55B | 228.03 | ― | 0.39% | 6.17% | -8918.66% | |
63 Neutral | ¥211.37B | 26.76 | ― | 0.43% | 20.55% | 48.62% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | ¥61.48B | 77.03 | 5.76% | ― | 31.95% | -40.95% | |
44 Neutral | ¥2.71B | -4.28 | ― | ― | 16.19% | -4.42% |
* Healthcare Sector Average
JP:3939
Kanamic Network Co., LTD.
506.00
85.56
20.35%
JP:4480
Medley
1,878.00
-1,152.00
-38.02%
JP:3902
Medical Data Vision Co.Ltd.
1,681.00
1,278.00
317.12%
JP:4438
Welby Inc.
328.00
-31.00
-8.64%
JP:4483
JMDC Inc.
3,230.00
483.36
17.60%
JP:9341
GENOVA Inc.
548.00
-390.76
-41.63%
Kanamic Network Co., LTD. Corporate Events
Kanamic Network Delivers Strong Q1 Growth and Affirms Bullish FY2026 Outlook
Feb 5, 2026
Kanamic Network reported strong consolidated results for the first quarter of the fiscal year ending September 30, 2026, with net sales rising 12.9% year on year to ¥1,478 million and profit attributable to owners of parent climbing 29.5% to ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.